SFRP2 and PD-1 immunotherapy combination halts osteosarcoma metastasis in model
In a cancer that has not seen new targeted therapies for over 20 years, MUSC Hollings Cancer Center researcher and […]
PD-1
In a cancer that has not seen new targeted therapies for over 20 years, MUSC Hollings Cancer Center researcher and […]PD-1
SFRP2 and PD-1 immunotherapy combination halts osteosarcoma metastasis in model
Copyright © 2024